Skip to main content

Table 4 Relationship between tumor location and clinicopathologic factors of NSCLC patients

From: Resectable left lower lobe non–small cell lung cancer with lymph node metastasis is related to unfavorable outcomes

Characteristic

Node-negative patients (pN0)

Node-positive patients (pN1–2)

LLL (n = 66)

Non-LLL (n = 324)

P

LLL (n = 41)

Non-LLL (n = 196)

P

Sex

  

0.702

  

0.264

 Men

47 (71.2)

223 (68.8)

 

25 (61.0)

137 (69.9)

 

 Women

19 (28.8)

101 (31.2)

 

16 (39.0)

59 (30.1)

 

Age

  

0.341

  

0.463

 ≤60 years

31 (47.0)

173 (53.4)

 

27 (65.9)

117 (59.7)

 

 >60 years

35 (53.0)

151 (46.6)

 

14 (34.1)

79 (40.3)

 

T category

  

0.291

  

1.000b

 T1

9 (13.6)

59 (18.2)

 

4 (9.8)

18 (9.2)

 

 T2

45 (68.2)

227 (70.1)

 

33 (80.5)

157 (80.1)

 

 T3

12 (18.2)

38 (11.7)

 

4 (9.8)

21 (10.7)

 

N category

  

NA

  

0.170

 N1

0

0

 

15 (36.6)

51 (26.0)

 

 N2

0

0

 

26 (63.4)

145 (74.0)

 

TNM stage

  

0.445c

  

0.081d

 Ia/b

63 (95.5)

299 (92.3)

 

0

0

 

 IIa/b

3 (4.5)

25 (7.7)

 

15 (36.6)

46 (23.5)

 

 IIIa

0

0

 

26 (63.4)

150 (76.5)

 

Histology

  

0.260

  

1.000b

 AC

30 (45.5)

183 (56.5)

 

26 (63.4)

124 (63.3)

 

 SCC

27 (40.9)

105 (32.4)

 

10 (24.4)

49 (25.0)

 

 Others

9 (13.6)

36 (11.1)

 

5 (12.2)

23 (11.7)

 

Histology grade

  

0.023

  

0.256b

 G1

14 (21.2)

68 (21.0)

 

2 (4.9)

19 (9.7)

 

 G2

13 (19.7)

117 (36.1)

 

10 (24.4)

66 (33.7)

 

 G3

39 (59.1)

139 (42.9)

 

29 (70.7)

111 (56.6)

 

Tumor size

  

<0.001

  

0.801

 ≤4 cm

29 (43.9)

230 (71.0)

 

27 (65.9)

125 (63.8)

 

 >4 cm

37 (56.1)

94 (29.0)

 

14 (34.1)

71 (36.2)

 

Pleural invasion

  

0.343

  

1.000b

 Yes

57 (86.4)

264 (81.5)

 

37 (90.2)

178 (90.8)

 

 No

9 (13.6)

60 (18.5)

 

4 (9.8)

18 (9.2)

 

Adjuvant chemotherapy

  

0.063

  

0.050

 Yes

9 (13.6)

78 (24.1)

 

30 (73.2)

111 (56.6)

 

 No

57 (86.4)

246 (75.9)

 

11 (26.8)

85 (43.4)

 

No. of MLNs dissecteda

4 (3, 17)

7.5 (3, 44)

<0.001

5 (3, 14)

8 (3, 38)

<0.001

  1. Abbreviations as in Tables 2 and 3
  2. aThe data are presented as medians followed by the range in the parenthese and analyzed by Mann-Whitney U test; other values are presented as the number of patients followed by the percentage in the parentheses
  3. bFisher’s exact test
  4. cComparison between patients with stages Ia/b and IIa/b NSCLC
  5. dComparison between patients with stages IIa/b and IIIa NSCLC